Mesoblast (MEOBF) director Jane Bell reports options and 622,492 shares
Filing Impact
Filing Sentiment
Form Type
3
Rhea-AI Filing Summary
Mesoblast Ltd director Jane Catherine Bell has filed an initial Form 3 reporting her equity interests in the company. The filing lists multiple options to buy Ordinary Shares, including options over 108,910 shares at an exercise price of 0.3600 per share expiring on 2030-10-11, and options over 64,103 shares at an exercise price of 0.9700 per share expiring on 2031-08-26. It also reports indirect ownership of 622,492 Ordinary Shares held by Ms. Bell and Geoffrey Arthur Bell as trustees for Ms. Bell's self-managed superannuation fund.
Positive
- None.
Negative
- None.
Insider Trade Summary
10 transactions reported
Mixed
10 txns
Insider
BELL JANE CATHERINE
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Option (right to buy) | -- | -- | -- |
| holding | Option (right to buy) | -- | -- | -- |
| holding | Option (right to buy) | -- | -- | -- |
| holding | Option (right to buy) | -- | -- | -- |
| holding | Option (right to buy) | -- | -- | -- |
| holding | Option (right to buy) | -- | -- | -- |
| holding | Option (right to buy) | -- | -- | -- |
| holding | Option (right to buy) | -- | -- | -- |
| holding | Option (right to buy) | -- | -- | -- |
| holding | Ordinary Shares | -- | -- | -- |
Holdings After Transaction:
Option (right to buy) — 66,667 shares (Direct);
Ordinary Shares — 622,492 shares (Indirect, By Ms. Bell and Mr. Geoffrey Arthur Bell as trustees for Ms. Bell's self-managed superannuation fund)
Footnotes (1)
FAQ
What does Mesoblast (MEOBF) director Jane Catherine Bell report on her Form 3?
Jane Catherine Bell reports her existing equity interests in Mesoblast Ltd, including several option positions over Ordinary Shares and an indirect holding of 622,492 Ordinary Shares through a self-managed superannuation fund, reflecting her baseline ownership as she becomes a reporting insider.
What stock options held by Jane Catherine Bell in Mesoblast (MEOBF) are disclosed?
The Form 3 lists options to buy Mesoblast Ordinary Shares, including tranches over 108,910 shares at an exercise price of 0.3600 per share and 64,103 shares at 0.9700 per share, with expirations extending to 2030-10-11 and 2031-08-26.
Are there any buy or sell transactions in Jane Catherine Bell’s Mesoblast (MEOBF) Form 3?
No buy or sell transactions are reported. The Form 3 records holdings only, with transaction codes and directions shown as unknown and transaction_type marked as holding, indicating this is an initial statement of beneficial ownership rather than a record of recent trades.
What is the significance of the expiration dates on Jane Catherine Bell’s Mesoblast (MEOBF) options?
The expiration dates, running through 2029-08-23, 2030-10-11 and 2031-08-26, show how long Ms. Bell retains the right to buy Mesoblast Ordinary Shares at specified exercise prices, outlining a multi-year window for potential future share acquisitions.